(Millions of yen)
Year Ended March 31, 2020 |
Year Ended March 31, 2021 |
Year Ended March 31, 2022 |
Year Ended March 31, 2023 |
Year Ended March 31, 2024 |
Year Ended March 31, 2025 |
|
---|---|---|---|---|---|---|
Net sales | 181,232 | 169,573 | 187,018 | 207,589 | 229,401 | 241,253 |
Operating income | 13,375 | 13,288 | 13,777 | 11,618 | 14,571 | 16,171 |
Ordinary income | 14,682 | 14,633 | 15,713 | 13,331 | 18,717 | 18,866 |
Profit attributable to owners of parent | 9,916 | 9,287 | 10,835 | 8,433 | 17,830 | 14,514 |
Net assets | 118,714 | 125,264 | 140,482 | 144,117 | 165,177 | 170,635 |
Total assets | 193,581 | 205,196 | 220,609 | 230,098 | 256,402 | 262,257 |
Interest-bearing debt | 4,901 | 3,720 | 4,505 | 11,886 | 8,349 | 7,050 |
Shareholders' equity ratio(%) | 55.2 | 54.8 | 56.9 | 55.6 | 57.9 | 59.3 |
Cash flows from operating activities | 11,078 | 21,542 | 9,846 | △2,346 | 17,498 | 15,402 |
Cash flows from investing activities | -4,341 | -7,955 | -3,994 | 1,949 | 433 | 16,514 |
Cash flows from financing activities | -3,800 | -5,866 | -6,520 | △10,670 | △12,104 | △19,270 |
Free cash flows | 6,736 | 13,586 | 5,852 | -397 | 17,931 | 31,917 |
Cash and cash equivalents at end of year | 28,181 | 35,840 | 39,042 | 31,463 | 38,987 | 54,738 |
R&D expenditures | 2,208 | 2,121 | 2,662 | 2,590 | 2,974 | 3,161 |
Capital investment | 3,523 | 2,831 | 4,088 | 4,527 | 4,120 | 8,531 |
Number of employees (persons) | 10,292 | 10,423 | 10,683 | 11,453 | 11,818 | 11,777 |
Net income per share(yen) | 122.46 | 114.52 | 133.42 | 106.67 | 228.55 | 185.99 |
Diluted net income per share(yen) | 122.40 | 114.46 | 133.36 | 106.61 | 228.44 | 185.90 |
Net assets per share(yen) | 1,318.59 | 1,385.45 | 1,549.83 | 1,640.29 | 1,901.28 | 1,994.06 |
Cash dividends per share(yen) | 50 | 60 | 70 | 75 | 155 | 165 |
Return on shareholders' equity (ROE) (%) | 9.5 | 8.5 | 9.1 | 6.7 | 12.9 | 9.5 |